Mannkind (MNKD) Revenue (2010 - 2026)
Mannkind's (MNKD) quarterly Revenue came in at $90.2 million in Q1 2026, up 15.08% year-on-year from $78.4 million in Q1 2025, and down 19.46% on a QoQ basis from $112.0 million in Q4 2025.
Mannkind (MNKD) Revenue (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 14 years of Revenue data on file, last reported at $90.2 million in Q1 2026.
- On a quarterly basis, Revenue rose 15.08% year-over-year to $90.2 million in Q1 2026; TTM through Mar 2026 was $360.8 million, a 21.23% increase from a year earlier, with the FY2025 full-year figure at $349.0 million, up 22.23% from the prior year.
- Revenue for Q1 2026 stood at $90.2 million, down from $112.0 million in the prior quarter.
- Over the last five years, Revenue for MNKD reached as high as $112.0 million in Q4 2025 and fell as low as $12.0 million in Q1 2022.
- Historically, Revenue has averaged $60.2 million across 5 years, with a median of $66.3 million in 2024.
- Across the five-year window, Revenue tumbled 31.22% in 2022 and soared 238.78% in 2023, its largest moves.
- Year by year, Revenue stood at $36.1 million in 2022, then soared by 62.16% to $58.5 million in 2023, then surged by 31.3% to $76.8 million in 2024, then surged by 45.82% to $112.0 million in 2025, then retreated by 19.46% to $90.2 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $90.2 million in Q1 2026, $112.0 million in Q4 2025, and $82.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | 90.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.17 Mn |
| Dec 31, 2025 | 111.96 Mn |
| Sep 30, 2025 | 82.13 Mn |
| Jun 30, 2025 | 76.53 Mn |
| Mar 31, 2025 | 78.35 Mn |
| Dec 31, 2024 | 76.78 Mn |
| Sep 30, 2024 | 70.08 Mn |
| Jun 30, 2024 | 72.39 Mn |
| Mar 31, 2024 | 66.26 Mn |
| Dec 31, 2023 | 58.47 Mn |
| Sep 30, 2023 | 51.25 Mn |
| Jun 30, 2023 | 48.61 Mn |
| Mar 31, 2023 | 40.63 Mn |
| Dec 31, 2022 | 36.06 Mn |
| Sep 30, 2022 | 32.83 Mn |
| Jun 30, 2022 | 18.89 Mn |
| Mar 31, 2022 | 11.99 Mn |
| Dec 31, 2021 | 12.52 Mn |
| Sep 30, 2021 | 22.21 Mn |
| Jun 30, 2021 | 23.28 Mn |